158091-64-6Relevant articles and documents
Conversion of 2,4,6-Trimethylaniline to 3-(Mesitylthio)-1 H-1,2,4-triazole Using a Continuous-Flow Reactor
Yu, Zhiqun,Chen, Jianyang,Liu, Jiming,Wu, Zhengkang,Su, Weike
, p. 1828 - 1834 (2018)
An expeditious and highly efficient continuous-flow process was developed for the synthesis of 3-(mesitylthio)-1H-1,2,4-triazole. The starting material 2,4,6-trimethylaniline was diazotized to give diazonium chloride, followed by azo-coupling with 1H-1,2,4-triazole-3-thiol and dediazoniation to provide 3-(mesitylthio)-1H-1,2,4-triazole in 85% yield with a productivity of 344 g/h. The side reactions such as hydrolysis, dimerization, and intramolecular coupling were significantly inhibited by the continuous-flow technology.
Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials
McConville, Matthew,Fernández, Jorge,Angulo-Barturen, í?igo,Bahamontes-Rosa, Noemi,Ballell-Pages, Lluis,Casta?eda, Pablo,De Cózar, Cristina,Crespo, Benigno,Guijarro, Laura,Jiménez-Díaz, María Belén,Martínez-Martínez, Maria S.,De Mercado, Jaime,Santos-Villarejo, ángel,Sanz, Laura M.,Frigerio, Micol,Washbourn, Gina,Ward, Stephen A.,Nixon, Gemma L.,Biagini, Giancarlo A.,Berry, Neil G.,Blackman, Michael J.,Calderón, Félix,O'Neill, Paul M.
supporting information, p. 6448 - 6455 (2015/09/08)
(Graph Presented) Screening of the GSK corporate collection, some 1.9 million compounds, against Plasmodium falciparum (Pf), revealed almost 14000 active hits that are now known as the Tres Cantos Antimalarial Set (TCAMS). Followup work by Calderon et al.
Pharmaceutical use of N-Carbamoylazole derivatives
-
Page 24-25, (2010/11/29)
The present invention relates to use of 1-carbamoylazole derivatives as medicaments and pharmaceutical compositions containing 1-carbamoylazole derivatives as the active ingredient, based on their DPPIV inhibiting effects. The present invention provides a dipeptidyl peptidase IV inhibiting agent comprising a compound represented by the general formula (I):